Core Alternative Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.4K | Hold |
700
| – | – | 0.01% | 148 |
|
|
2025
Q1 | $42.7K | Hold |
700
| – | – | 0.01% | 137 |
|
|
2024
Q4 | $39.6K | Hold |
700
| – | – | 0.01% | 152 |
|
|
2024
Q3 | $36.2K | Hold |
700
| – | – | 0.01% | 155 |
|
|
2024
Q2 | $29.1K | Hold |
700
| – | – | 0.01% | 171 |
|
|
2024
Q1 | $38K | Sell |
700
-992
| -59% | -$53.8K | 0.01% | 158 |
|
|
2023
Q4 | $86.8K | Sell |
1,692
-2,088
| -55% | -$107K | 0.01% | 137 |
|
|
2023
Q3 | $219K | Sell |
3,780
-68
| -2% | -$3.95K | 0.03% | 115 |
|
|
2023
Q2 | $246K | Buy |
3,848
+8
| +0.2% | +$512 | 0.04% | 90 |
|
|
2023
Q1 | $266K | Sell |
3,840
-179
| -4% | -$12.4K | 0.04% | 84 |
|
|
2022
Q4 | $289K | Buy |
4,019
+2,653
| +194% | +$191K | 0.04% | 93 |
|
|
2022
Q3 | $97K | Buy |
1,366
+66
| +5% | +$4.69K | 0.02% | 110 |
|
|
2022
Q2 | $100K | Buy |
1,300
+180
| +16% | +$13.8K | 0.02% | 116 |
|
|
2022
Q1 | $82K | Buy |
1,120
+674
| +151% | +$49.3K | 0.02% | 123 |
|
|
2021
Q4 | $28K | Buy |
446
+97
| +28% | +$6.09K | 0.01% | 127 |
|
|
2021
Q3 | $21K | Buy |
+349
| New | +$21K | ﹤0.01% | 89 |
|